J Breast Cancer.  2011 Mar;14(1):1-7. 10.4048/jbc.2011.14.1.1.

The Current Role of Vacuum Assisted Breast Biopsy System in Breast Disease

Affiliations
  • 1Division of Breast and Thyroid Surgery, Department of Surgery, Kangnam Cha Hospital, Cha University College of Medicine, Seoul, Korea. phl1@cha.ac.kr
  • 2Division of Breast & Endocrine Surgery, Hallym University Sacred Heart Hospital, Hallym University College of Medicine, Anyang, Korea.

Abstract

The gold standard for breast biopsy procedures is currently an open excision of the suspected lesion. However, an excisional biopsy inevitably makes a scar. The cost and morbidity associated with this procedure has prompted many physicians to evaluate less invasive, alternative procedures. More recently, image-guided percutaneous core-needle biopsy has become a frequently used method for diagnosing palpable and non-palpable breast lesions. Although sensitivity rates for core-needle biopsy are high, it has the disadvantage of histological underestimation, which renders the management of atypical ductal hyperplasia, papillary lesions, and fibroepithelial lesions somewhat difficult. Vacuum assisted breast biopsy (VABB) was developed to overcome some of these negative aspects of core-needle biopsy. VABB allows for a sufficient specimen to be obtained with a single insertion and can provide a more accurate diagnosis and completely remove the lesion under real-time ultrasonic guidance. The advantage of complete lesion removal with VABB is to reduce or eliminate sampling error, to decrease the likelihood of a histological underestimation, to decrease imaging-histological discordance, to decrease the re-biopsy rate, and to diminish the likelihood of subsequent growth on follow-up. In recent years, with the advancement of VABB instruments and techniques, many outcome studies have reported on the use of VABB for resecting benign breast lesions with a curative intent. VABB is highly accurate for diagnosing suspicious breast lesions and is highly successful at treating presumed benign breast lesions. Thus, in the near future, VABB will be routinely offered to all appropriately selected patients.

Keyword

Breast tumor; Vacuum assisted breast biopsy

MeSH Terms

Biopsy
Breast
Breast Diseases
Breast Neoplasms
Cicatrix
Follow-Up Studies
Humans
Hyperplasia
Imidazoles
Nitro Compounds
Outcome Assessment (Health Care)
Selection Bias
Ultrasonics
Vacuum
Imidazoles
Nitro Compounds

Cited by  2 articles

Validation of a Scoring System for Predicting Malignancy in Patients Diagnosed with Atypical Ductal Hyperplasia Using an Ultrasound-Guided Core Needle Biopsy
Jisun Kim, Wonshik Han, Eun-Young Go, Hyeong-Gon Moon, Soo Kyung Ahn, Hee-Chul Shin, Jee-Man You, Jung Min Chang, Nariya Cho, Woo Kyung Moon, In Ae Park, Dong-Young Noh
J Breast Cancer. 2012;15(4):407-411.    doi: 10.4048/jbc.2012.15.4.407.

Absence of Residual Microcalcifications in Atypical Ductal Hyperplasia Diagnosed via Stereotactic Vacuum-Assisted Breast Biopsy: Is Surgical Excision Obviated?
Inyoung Youn, Min Jung Kim, Hee Jung Moon, Eun-Kyung Kim
J Breast Cancer. 2014;17(3):265-269.    doi: 10.4048/jbc.2014.17.3.265.


Reference

1. American College of Radiology. Breast imaging reporting and data system (BI-RADS). 2003. 4th ed. Reston: American College of Radiology.
2. Varas X, Leborgne F, Leborgne JH. Nonpalpable, probably benign lesions: role of follow-up mammography. Radiology. 1992. 184:409–414.
Article
3. Sickles EA. Probably benign breast lesions: when should follow-up be recommended and what is the optimal follow-up protocol? Radiology. 1999. 213:11–14.
Article
4. Stavros AT, Thickman D, Rapp CL, Dennis MA, Parker SH, Sisney GA. Solid breast nodules: use of sonography to distinguish between benign and malignant lesions. Radiology. 1995. 196:123–134.
Article
5. Graf O, Helbich TH, Fuchsjaeger MH, Hopf G, Morgun M, Graf C, et al. Follow-up of palpable circumscribed noncalcified solid breast masses at mammography and US: can biopsy be averted? Radiology. 2004. 233:850–856.
Article
6. Houssami N, Cheung MN, Dixon JM. Fibroadenoma of the breast. Med J Aust. 2001. 174:185–188.
Article
7. Stavros AT. Stavros AT, editor. Ultrasound of solid breast nodules: distinguishing benign from malignant. Breast Ultrasound. 2004. Philadelphia: Lippincott Williams & Wilkins;445–525.
8. Parker SH, Jobe WE, Dennis MA, Stavros AT, Johnson KK, Yakes WF, et al. US-guided automated large-core breast biopsy. Radiology. 1993. 187:507–511.
Article
9. Liberman L, Feng TL, Dershaw DD, Morris EA, Abramson AF. US-guided core breast biopsy: use and cost-effectiveness. Radiology. 1998. 208:717–723.
Article
10. Smith DN, Rosenfield Darling ML, Meyer JE, Denison CM, Rose DI, Lester S, et al. The utility of ultrasonographically guided large-core needle biopsy: results from 500 consecutive breast biopsies. J Ultrasound Med. 2001. 20:43–49.
Article
11. Pisano ED, Fajardo LL, Tsimikas J, Sneige N, Frable WJ, Gatsonis CA, et al. Rate of insufficient samples for fine-needle aspiration for nonpalpable breast lesions in a multicenter clinical trial: The Radiologic Diagnostic Oncology Group 5 Study. The RDOG5 investigators. Cancer. 1998. 82:679–688.
Article
12. Chaiwun B, Settakorn J, Ya-In C, Wisedmongkol W, Rangdaeng S, Thorner P. Effectiveness of fine-needle aspiration cytology of breast: analysis of 2,375 cases from northern Thailand. Diagn Cytopathol. 2002. 26:201–205.
Article
13. Burbank F, Parker SH. Methods for evaluating the quality of an image-guided breast biopsy program. Semin Breast Dis. 1998. 1:71–83.
14. Parker SH, Dennis MA, Stavros AT, Johnson KK. Ultrasound-guided mamtmeotomoy: a new breast biopsy technique. J Diagn Med Sonogr. 1996. 12:113–118.
15. Parker SH, Klaus AJ, McWey PJ, Schilling KJ, Cupples TE, Duchesne N, et al. Sonographically guided directional vacuum-assisted breast biopsy using a handheld device. AJR Am J Roentgenol. 2001. 177:405–408.
Article
16. Grady I, Gorsuch H, Wilburn-Bailey S. Ultrasound-guided, vacuum-assisted, percutaneous excision of breast lesions: an accurate technique in the diagnosis of atypical ductal hyperplasia. J Am Coll Surg. 2005. 201:14–17.
Article
17. Burbank F. Stereotactic breast biopsy: comparison of 14- and 11-gauge Mammotome probe performance and complication rates. Am Surg. 1997. 63:988–995.
18. Jackman RJ, Marzoni FA Jr, Rosenberg J. False-negative diagnoses at stereotactic vacuum-assisted needle breast biopsy: long-term follow-up of 1,280 lesions and review of the literature. AJR Am J Roentgenol. 2009. 192:341–351.
Article
19. Jackman RJ, Birdwell RL, Ikeda DM. Atypical ductal hyperplasia: can some lesions be defined as probably benign after stereotactic 11-gauge vacuum-assisted biopsy, eliminating the recommendation for surgical excision? Radiology. 2002. 224:548–554.
Article
20. Baez E, Huber A, Vetter M, Hackelöer BJ. Minimal invasive complete excision of benign breast tumors using a three-dimensional ultrasound-guided mammotome vacuum device. Ultrasound Obstet Gynecol. 2003. 21:267–272.
Article
21. Zografos GC, Zagouri F, Sergentanis TN, Nonni A, Michalopoulos NV, Kontogianni P, et al. Diagnosing papillary lesions using vacuum-assisted breast biopsy: should conservative or surgical management follow? Onkologie. 2008. 31:653–656.
Article
22. Park HL, Chang SY, Huh JY, Kim JY. Is further diagnostic surgery necessary for the benign papillary lesions that are diagnosed by large volume vacuum assisted breast biopsy? J Breast Cancer. 2010. 13:206–211.
Article
23. Johnson AT, Henry-Tillman RS, Smith LF, Harshfield D, Korourian S, Brown H, et al. Percutaneous excisional breast biopsy. Am J Surg. 2002. 184:550–554.
Article
24. Sperber F, Blank A, Metser U, Flusser G, Klausner JM, Lev-Chelouche D. Diagnosis and treatment of breast fibroadenomas by ultrasound-guided vacuum-assisted biopsy. Arch Surg. 2003. 138:796–800.
Article
25. Park HL, Kwak JY, Lee SH, Kim JY, Kim KI, Kim WW, et al. Excision of benign breast disease by ultrasound-guided vacuum assisted biopsy device (Mammotome). J Korean Surg Soc. 2005. 68:96–101.
26. Park HL, Kwak JY, Jung H, Lee SH, Shim JY, Kim JY, et al. Is mammotome excision feasible for benign breast mass bigger than 3 cm in greatest dimension? J Korean Surg Soc. 2006. 70:25–29.
27. Park HL, Kwak JY, Lee SH, Jung HK, Kim JY, Shim JY, et al. Excision of benign breast tumor by an ultrasound-guided hand held Mammotome biopsy device. J Breast Cancer. 2005. 8(3):92–98.
Article
28. Tagaya N, Nakagawa A, Ishikawa Y, Oyama T, Kubota K. Experience with ultrasonographically guided vacuum-assisted resection of benign breast tumors. Clin Radiol. 2008. 63:396–400.
Article
29. Fine RE, Israel PZ, Walker LC, Corgan KR, Greenwald LV, Berenson JE, et al. A prospective study of the removal rate of imaged breast lesions by an 11-gauge vacuum-assisted biopsy probe system. Am J Surg. 2001. 182:335–340.
Article
30. Fine RE, Boyd BA, Whitworth PW, Kim JA, Harness JK, Burak WE. Percutaneous removal of benign breast masses using a vacuum-assisted hand-held device with ultrasound guidance. Am J Surg. 2002. 184:332–336.
Article
31. Govindarajulu S, Narreddy S, Shere MH, Ibrahim NB, Sahu AK, Cawthorn SJ. Preoperative mammotome biopsy of ducts beneath the nipple areola complex. Eur J Surg Oncol. 2006. 32:410–412.
Article
32. Brown TA, Wall JW, Christensen ED, Smith DV, Holt CA, Carter PL, et al. Atypical hyperplasia in the era of stereotactic core needle biopsy. J Surg Oncol. 1998. 67:168–173.
Article
33. Gadzala DE, Cederbom GJ, Bolton JS, McKinnon WM, Farr GH Jr, Champaign J, et al. Appropriate management of atypical ductal hyperplasia diagnosed by stereotactic core needle breast biopsy. Ann Surg Oncol. 1997. 4:283–286.
Article
34. Jackman RJ, Nowels KW, Shepard MJ, Finkelstein SI, Marzoni FA Jr. Stereotaxic large-core needle biopsy of 450 nonpalpable breast lesions with surgical correlation in lesions with cancer or atypical hyperplasia. Radiology. 1994. 193:91–95.
Article
35. Liberman L, Smolkin JH, Dershaw DD, Morris EA, Abramson AF, Rosen PP. Calcification retrieval at stereotactic, 11-gauge, directional, vacuum-assisted breast biopsy. Radiology. 1998. 208:251–260.
Article
36. Jackman RJ, Burbank F, Parker SH, Evans WP 3rd, Lechner MC, Richardson TR, et al. Atypical ductal hyperplasia diagnosed at stereotactic breast biopsy: improved reliability with 14-gauge, directional, vacuum-assisted biopsy. Radiology. 1997. 204:485–488.
Article
37. Jackman RJ, Burbank F, Parker SH. Atypical ductal hyperplasia diagnosed by 11-gauge, directional, vacuum-assisted breast biopsy: how often is carcinoma found at surgery? [abstract]. Radiology. 1997. 205:A325.
38. Liberman L, Hann LE, Dershaw DD, Morris EA, Abramson AF, Rosen PP. Mammographic findings after stereotactic 14-gauge vacuum biopsy. Radiology. 1997. 203:343–347.
Article
39. Burbank F. Mammographic findings after 14-gauge automated needle and 14-gauge directional, vacuum-assisted stereotactic breast biopsies. Radiology. 1997. 204:153–156.
Article
40. Diaz LK, Wiley EL, Venta LA. Are malignant cells displaced by large-gauge needle core biopsy of the breast? AJR Am J Roentgenol. 1999. 173:1303–1313.
Article
41. Liberman L, Vuolo M, Dershaw DD, Morris EA, Abramson AF, LaTrenta LR, et al. Epithelial displacement after stereotactic 11-gauge directional vacuum-assisted breast biopsy. AJR Am J Roentgenol. 1999. 172:677–681.
Article
42. Liberman L, Dershaw DD, Rosen PP, Abramson AF, Deutch BM, Hann LE. Stereotaxic 14-gauge breast biopsy: how many core biopsy specimens are needed? Radiology. 1994. 192:793–795.
Article
43. Parker SH, Burbank F. A practical approach to minimally invasive breast biopsy. Radiology. 1996. 200:11–20.
Article
44. Parker SH, Klaus AJ. Performing a breast biopsy with a directional, vacuum-assisted biopsy instrument. Radiographics. 1997. 17:1233–1252.
Article
45. Berg JW, Robbins GF. A late look at the safety of aspiration biopsy. Cancer. 1962. 15:826–827.
Article
46. Robbins GF, Brothers JH 3rd, Eberhart WF, Quan S. Is aspiration biopsy of breast cancer dangerous to the patient? Cancer. 1954. 7:774–778.
Article
47. Krainick-Strobel U, Huber B, Majer I, Bergmann A, Gall C, Gruber I, et al. Complete extirpation of benign breast lesions with an ultrasound-guided vacuum biopsy system. Ultrasound Obstet Gynecol. 2007. 29:342–346.
Article
48. Fine RE, Whitworth PW, Kim JA, Harness JK, Boyd BA, Burak WE Jr. Low-risk palpable breast masses removed using a vacuum-assisted hand-held device. Am J Surg. 2003. 186:362–367.
Article
49. Jackman RJ, Marzoni FA Jr, Nowels KW. Percutaneous removal of benign mammographic lesions: comparison of automated large-core and directional vacuum-assisted stereotactic biopsy techniques. AJR Am J Roentgenol. 1998. 171:1325–1330.
Article
50. March DE, Coughlin BF, Barham RB, Goulart RA, Klein SV, Bur ME, et al. Breast masses: removal of all US evidence during biopsy by using a handheld vacuum-assisted device--initial experience. Radiology. 2003. 227:549–555.
Article
51. Vargas HI, Vargas MP, Gonzalez K, Burla M, Khalkhali I. Percutaneous excisional biopsy of palpable breast masses under ultrasound visualization. Breast J. 2006. 12:5 Suppl 2. S218–S222.
Article
52. Simon JR, Kalbhen CL, Cooper RA, Flisak ME. Accuracy and complication rates of US-guided vacuum-assisted core breast biopsy: initial results. Radiology. 2000. 215:694–697.
Article
53. Perez-Fuentes JA, Longobardi IR, Acosta VF, Marin CE, Liberman L. Sonographically guided directional vacuum-assisted breast biopsy: preliminary experience in Venezuela. AJR Am J Roentgenol. 2001. 177:1459–1463.
54. Chen SC, Yang HR, Hwang TL, Chen MF, Cheung YC, Hsueh S. Intraoperative ultrasonographically guided excisional biopsy or vacuum-assisted core needle biopsy for nonpalpable breast lesions. Ann Surg. 2003. 238:738–742.
Article
Full Text Links
  • JBC
Actions
Cited
CITED
export Copy
Close
Share
  • Twitter
  • Facebook
Similar articles
Copyright © 2024 by Korean Association of Medical Journal Editors. All rights reserved.     E-mail: koreamed@kamje.or.kr